Armistice Capital, LLC Pds Biotechnology Corp Transaction History
Armistice Capital, LLC
- $6.56 Billion
- Q1 2025
A detailed history of Armistice Capital, LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Armistice Capital, LLC holds 4,419,000 shares of PDSB stock, worth $6.19 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
4,419,000Holding current value
$6.19 Million% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding PDSB
# of Institutions
54Shares Held
8.16MCall Options Held
151KPut Options Held
1.2K-
Vanguard Group Inc Valley Forge, PA1.51MShares$2.11 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$681,7530.0% of portfolio
-
Geode Capital Management, LLC Boston, MA438KShares$613,0330.0% of portfolio
-
Blair William & CO Chicago, IL257KShares$360,0800.0% of portfolio
-
Ubs Group Ag251KShares$351,6180.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $39.8M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...